# IBANDRONATE SODIUM

NDC: 60505-2795
Generic name: IBANDRONATE SODIUM
Labeler / Manufacturer: Apotex Corp
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20120319

FDA application: ANDA078948

## Active ingredients

- IBANDRONATE SODIUM: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-2795"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-2795
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd674424-b151-d7eb-3acf-b1589347f2f7